Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma-Reference-Cited by-同舟云学术

Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma

Published:2019-08-08 Issue:15 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Sethi Nilay,Kikuchi Osamu,McFarland James,Zhang Yanxi,Chung Max,Kafker Nicholas,Islam Mirazul^ORCID,Lampson Benjamin,Chakraborty Abhishek,Kaelin William G.,Bass Adam J.

Funder

National Cancer Institute

American Cancer Society

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/128439/files/pdf

Reference70 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Integrated genomic characterization of oesophageal carcinoma

3. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity

4. Comprehensive molecular characterization of gastric adenocarcinoma

5. Accumulation of Somatic Mutations in TP53 in Gastric Epithelium With Helicobacter pylori Infection

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRas, in addition to Tp53 is a driver for early carcinogenesis and a molecular target in a mouse model of invasive gastro-esophageal adenocarcinoma;2024-05-10

2. Tumor hypoxia and role of hypoxia-inducible factor in oral cancer;World Journal of Surgical Oncology;2024-01-11

3. In silico prediction and biological assessment of novel angiogenesis modulators from traditional Chinese medicine;Frontiers in Pharmacology;2023-02-03

4. Establishment and characterization of two Epstein–Barr virus‐positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles;Journal of Medical Virology;2022-12-15

5. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia;Endocrine Reviews;2022-10-27